Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.

NCT04311489 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Interim analysis showing safety concerns

Conditions

Cirrhosis, Liver
Ascites Hepatic

Interventions

DRUG: Ularitide
DRUG: Placebo

Sponsor

University of Aarhus

Collaborators

[object Object]
[object Object]